Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JOINTSTEM in severe Knee Osteoarthritis
NCT03990805Phase 3Completed
- Sponsor
- R Bio
- Start
- Jun 2019
- Primary completion
- Dec 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing JOINTSTEM with Placebo (2 arms). Primary endpoints: Western Ontario and McMaster Universities Osteoarthritis Index at 24 weeks and Visual Analog Scale at 24 weeks. Started Jun 2019; status: completed.
02
Drugs
JOINTSTEM
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03990805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03990805.